The M@BS-QE NPs constructed by Zhao et al. were recruited to the tumor surface through the CCL-2-dependent mechanism brought by the macrophage membrane, thereby endowing the M@BS-QE NPs with excellent tumor-targeting ability [106]. The gene discussed is CCL2; the disease is neoplasm.